Cargando…
Immune Responses Regulated by Cannabidiol
Introduction: Cannabidiol (CBD) as Epidiolex(®) (GW Pharmaceuticals) was recently approved by the U.S. Food and Drug Administration (FDA) to treat rare forms of epilepsy in patients 2 years of age and older. Together with the increased societal acceptance of recreational cannabis and CBD oil for put...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Mary Ann Liebert, Inc., publishers
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173676/ https://www.ncbi.nlm.nih.gov/pubmed/32322673 http://dx.doi.org/10.1089/can.2018.0073 |